Search by Drug Name or NDC

    NDC 62856-0584-46 Banzel 40 mg/mL Details

    Banzel 40 mg/mL

    Banzel is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eisai Inc.. The primary component is RUFINAMIDE.

    Product Information

    NDC 62856-0584
    Product ID 62856-584_e2b636a9-79ad-4804-b5f9-c9be2713e84b
    Associated GPIs 72600065001820
    GCN Sequence Number 067131
    GCN Sequence Number Description rufinamide ORAL SUSP 40 MG/ML ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 29462
    HICL Sequence Number 034982
    HICL Sequence Number Description RUFINAMIDE
    Brand/Generic Brand
    Proprietary Name Banzel
    Proprietary Name Suffix n/a
    Non-Proprietary Name rufinamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/mL
    Substance Name RUFINAMIDE
    Labeler Name Eisai Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA201367
    Listing Certified Through 2024-12-31

    Package

    NDC 62856-0584-46 (62856058446)

    NDC Package Code 62856-584-46
    Billing NDC 62856058446
    Package 1 BOTTLE in 1 CARTON (62856-584-46) / 460 mL in 1 BOTTLE
    Marketing Start Date 2011-03-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.67035
    Pricing Unit ML
    Effective Date 2023-05-17
    NDC Description BANZEL 40 MG/ML SUSPENSION
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis